215 related articles for article (PubMed ID: 23328977)
1. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
Li SC; Essaghir A; Martijn C; Lloyd RV; Demoulin JB; Oberg K; Giandomenico V
Mod Pathol; 2013 May; 26(5):685-96. PubMed ID: 23328977
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs associated with small bowel neuroendocrine tumours and their metastases.
Miller HC; Frampton AE; Malczewska A; Ottaviani S; Stronach EA; Flora R; Kaemmerer D; Schwach G; Pfragner R; Faiz O; Kos-Kudła B; Hanna GB; Stebbing J; Castellano L; Frilling A
Endocr Relat Cancer; 2016 Sep; 23(9):711-26. PubMed ID: 27353039
[TBL] [Abstract][Full Text] [Related]
3. miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.
Arvidsson Y; Rehammar A; Bergström A; Andersson E; Altiparmak G; Swärd C; Wängberg B; Kristiansson E; Nilsson O
Mod Pathol; 2018 Aug; 31(8):1302-1317. PubMed ID: 29487354
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine.
Heverhagen AE; Legrand N; Wagner V; Fendrich V; Bartsch DK; Slater EP
Neuroendocrinology; 2018; 106(4):312-317. PubMed ID: 28848144
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.
Li SC; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
PLoS One; 2015; 10(5):e0125553. PubMed ID: 25942502
[TBL] [Abstract][Full Text] [Related]
6. Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas.
Leja J; Essaghir A; Essand M; Wester K; Oberg K; Tötterman TH; Lloyd R; Vasmatzis G; Demoulin JB; Giandomenico V
Mod Pathol; 2009 Feb; 22(2):261-72. PubMed ID: 18953328
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression.
Ruebel K; Leontovich AA; Stilling GA; Zhang S; Righi A; Jin L; Lloyd RV
Mod Pathol; 2010 Mar; 23(3):367-75. PubMed ID: 20037573
[TBL] [Abstract][Full Text] [Related]
8. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.
Sherman SK; Maxwell JE; Carr JC; Wang D; Bellizzi AM; Sue O'Dorisio M; O'Dorisio TM; Howe JR
Clin Exp Metastasis; 2014 Dec; 31(8):935-44. PubMed ID: 25241033
[TBL] [Abstract][Full Text] [Related]
9. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
Edfeldt K; Hellman P; Westin G; Stalberg P
BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets.
Andersson E; Arvidsson Y; Swärd C; Hofving T; Wängberg B; Kristiansson E; Nilsson O
Mod Pathol; 2016 Jun; 29(6):616-29. PubMed ID: 26965582
[TBL] [Abstract][Full Text] [Related]
11. Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study.
Mairinger FD; Ting S; Werner R; Walter RF; Hager T; Vollbrecht C; Christoph D; Worm K; Mairinger T; Sheu-Grabellus SY; Theegarten D; Schmid KW; Wohlschlaeger J
Mod Pathol; 2014 Dec; 27(12):1632-40. PubMed ID: 24875640
[TBL] [Abstract][Full Text] [Related]
12. Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection.
Malczewska A; Frampton AE; Mato Prado M; Ameri S; Dabrowska AF; Zagorac S; Clift AK; Kos-Kudła B; Faiz O; Stebbing J; Castellano L; Frilling A
Ann Surg; 2021 Jul; 274(1):e1-e9. PubMed ID: 31373926
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.
Malczewska A; Kidd M; Matar S; Kos-Kudla B; Modlin IM
Neuroendocrinology; 2018; 107(1):73-90. PubMed ID: 29566385
[TBL] [Abstract][Full Text] [Related]
14. Identification of microRNA signature and potential pathway targets in prostate cancer.
Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
[TBL] [Abstract][Full Text] [Related]
15. Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.
Kidd M; Modlin IM; Drozdov I
BMC Genomics; 2014 Jul; 15(1):595. PubMed ID: 25023465
[TBL] [Abstract][Full Text] [Related]
16. Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms.
Mandal R; Hardin H; Baus R; Rehrauer W; Lloyd RV
Endocr Pathol; 2017 Dec; 28(4):345-350. PubMed ID: 29032398
[TBL] [Abstract][Full Text] [Related]
17. Roles of miR-196a on gene regulation of neuroendocrine tumor cells.
Li SC; Shi H; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
Mol Cell Endocrinol; 2015 Sep; 412():131-9. PubMed ID: 26052033
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of small intestinal neuroendocrine tumors identified pathways and gene networks linked to tumorigenesis and metastasis.
Wang Q; Yu C
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496505
[TBL] [Abstract][Full Text] [Related]
19. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
[TBL] [Abstract][Full Text] [Related]
20. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
